Publications found:
36,694
Sort by:
Q Fever - Pipeline Review, H2 2017
US$ 2,000.00
... . The Q Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Q Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2017
36 pages
China Docusate Sodium Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
US$ 4,480.00
... display the China Docusate Sodium market. Chapter 1, to describe Docusate Sodium Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...
November 2017
120 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Ophthalmology Amniotic Membrane Market 2017 Forecast to 2022
US$ 4,880.00
... on the Ophthalmology Amniotic Membrane in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... Ophthalmics Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...
November 2017
116 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Pinaverium Bromide Market 2017 Forecast to 2022
US$ 4,880.00
... report focuses on the Pinaverium Bromide in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Group Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...
November 2017
116 pages
GLOBAL OPHTHALMIC DRUGS MARKET FORECAST 2017-2025
US$ 2,500.00
... market share in the global ophthalmic drugs market. Europe accounts for a second largest market share in the global ophthalmic drugs market. Asia-Pacific is estimated to expand at the highest CAGR during the forecast ...
November 2017
125 pages
Cushing's Syndrome - Market Insights, Epidemiology and Market Forecast – 2025
US$ 5,750.00
... Pipeline Analysis Cushing's Syndrome Market Size and Trends Cushing's Syndrome Market Opportunities Impact of upcoming Therapies in Cushing's Syndrome Cushing's Syndrome Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
November 2017
70 pages
PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2017
US$ 3,250.00
... . KEY COVERAGE AND BENEFITS: 1. In-depth analysis of the 50+ pipeline assets. 2. Pipeline landscape ... Technology implemented by companies in this space. 4. Licensing and Deals related to PD-1 and PD-L1 inhibitors are also covered. 5. Insights on marketed products including detailed marketed product profiles ...
November 2017
311 pages
Acne Vulgaris - Epidemiology Forecast to 2025
US$ 2,950.00
... 5 Business Days DelveInsight’s “Acne Vulgaris -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Acne Vulgaris in seven major markets (US, ... the global Acne Vulgaris market. Identifying prevalent patient populations as well as risk factors in the global Acne Vulgaris market will ...
November 2017
40 pages
Acne Vulgaris - Market Insights, Epidemiology and Market Forecast – 2025
US$ 5,750.00
... the Acne Vulgaris market. To understand the future market competition in the Acne Vulgaris market and Insightful review of the key market drivers and barriers. Organize sales and marketing efforts by identifying the best opportunities for Acne Vulgaris in US, Europe ...
November 2017
70 pages
Actinic Keratosis - Epidemiology Forecast to 2025
US$ 2,950.00
... Business Days DelveInsight’s “Actinic Keratosis -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Actinic Keratosis in seven major markets ... global Actinic Keratosis market. Identifying prevalent patient populations as well as risk factors in the global Actinic Keratosis market ...
November 2017
40 pages
Acute Respiratory Distress Syndrome - Epidemiology Forecast to 2025
US$ 2,950.00
... the trends shaping and driving the global Acute Respiratory Distress Syndrome market. Identifying prevalent patient populations as well as risk factors in the global Acute Respiratory Distress Syndrome market will help to improve product design ...
November 2017
40 pages
Allergic Conjunctivitis - Epidemiology Forecast to 2025
US$ 2,950.00
... Days DelveInsight’s “Allergic Conjunctivitis -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Allergic Conjunctivitis in seven major markets ... Allergic Conjunctivitis market. Identifying prevalent patient populations as well as risk factors in the global Allergic Conjunctivitis ...
November 2017
40 pages
Celiac Disease - Market Insights, Epidemiology and Market Forecast – 2025
US$ 5,750.00
... the Celiac Disease market. To understand the future market competition in the Celiac Disease market and Insightful review of the key market drivers and barriers. Organize sales and marketing efforts by identifying the best opportunities for Celiac Disease in US, Europe ...
November 2017
70 pages
Human Papillomavirus (HPV) Prophylaxis Landscape, 2017
US$ 6,000.00
... clients within 24 Hours DelveInsight’s ‘Human PapillomaVirus (HPV) Prophylaxis Landscape, 2017’ Report provides an overview of the Human PapillomaVirus (HPV) and market trends of the Human PapillomaVirus (HPV) Vaccines in the United States, EU5 ...
November 2017
79 pages
Merrem PWS IV- Generic sale global - API Insights, 2017
US$ 500.00
... advantage by identifying the key patent expiry details with respect to Merrem PWS IV- Generic sale global API intelligence over Merrem PWS IV- Generic sale global and gaining primary intelligence over Active Ingredient manufacturers by country Make more ...
November 2017
30 pages
Natural Killer Cells -Competitive Landscape, Technology and Pipeline Analysis, 2017
US$ 2,750.00
... involved in the therapeutic development of the products. SCOPE The report provides competitive pipeline landscape of Natural Killer Cells The report ... description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Natural Killer Cells pipeline on the basis of target ...
November 2017
207 pages
T-Bact - API Insights, 2017
US$ 500.00
... patent expiry details with respect to T-Bact API intelligence over T-Bact and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
November 2017
30 pages
Endometriosis - Epidemiology Forecast to 2025
US$ 2,950.00
... 10 years epidemiology historical and forecasted data of Insulin Resistance. The Report also discusses the prevailing risk factors, disease burden with ... and driving the global Endometriosis market. Identifying prevalent patient populations as well as risk factors in the global Endometriosis market will help to ...
November 2017
40 pages
Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017
US$ 6,950.00
... DelveInsight’s Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017 report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven ... the historical and forecasted epidemiology data for Diabetic Retinopathy prevalent or incident cases segmented by age, sex ...
November 2017
100 pages
Gastroparesis Drugs Market by Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections), Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, and Post-Surgical Gastroparesis), and End User (Hospitals, Pharmacies, Clinics, and E-commerce) - Global Opportunity Analysis and Industry Forecast, 2017-2023
US$ 5,540.00
... lucrative opportunities for the market expansion during the forecast period. The global gastroparesis drugs market is segmented on the basis of drug class, disease type ... The study provides an in-depth analysis of the global gastroparesis drugs market with current trends and future estimations from 2016 to 2023 ...
November 2017
231 pages
Anti-foaming Agents Market by Type (Water Based, Oil Based, Silicone Based, and Others) and Application (Pulp & Paper, Oil & Gas, Paints & Coatings, Water Treatment, Food & Beverages, Detergents, Pharmaceuticals, Textiles, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
US$ 4,999.00
... . The report segments the global anti-foaming agents market based on type, application, and region. Based on type, the market is segmented into water-based, ... and monitoring of top players within the market framework. Anti-foaming Agents Market key SEGMENTS: By Type Water Based Oil Based Silicone Based Others ...
November 2017
200 pages
Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
US$ 5,540.00
... known protein therapeutics and untapped emerging markets offer lucrative opportunities for the market players. The protein therapeutics market is segmented based product, application, and geography. By product, the market is divided ...
November 2017
211 pages
Ataxia - Market Insights, Epidemiology and Market Forecast-2027
US$ 6,250.00
... . Ataxia Report Insights Patient Population in Ataxia Therapeutic Approaches in Ataxia Ataxia Pipeline Analysis Ataxia Market Size and Trends Ataxia Market Opportunities Impact of upcoming Therapies in Ataxia Ataxia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology ...
November 2017
120 pages
Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022
US$ 2,200.00
... 45 CDK inhibitors are in various phases of clinical pipeline. “Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022” report highlights: Selectivity & Working Mechanism of a Cancer CDKs Inhibitor Recent Advances in the CDKs Related Cancer Therapy Global Cancer CDK Inhibitors Clinical Trials ...
November 2017
150 pages
